1. Home
  2. GNS vs RPID Comparison

GNS vs RPID Comparison

Compare GNS & RPID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Genius Group Limited

GNS

Genius Group Limited

SELL

Current Price

$0.49

Market Cap

32.1M

Sector

Real Estate

ML Signal

SELL

Logo Rapid Micro Biosystems Inc.

RPID

Rapid Micro Biosystems Inc.

SELL

Current Price

$0.74

Market Cap

34.7M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
GNS
RPID
Founded
2002
2006
Country
Singapore
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Medical Specialities
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
32.1M
34.7M
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
GNS
RPID
Price
$0.49
$0.74
Analyst Decision
Buy
Analyst Count
0
4
Target Price
N/A
★ $3.17
AVG Volume (30 Days)
★ 2.5M
1.1M
Earning Date
09-28-2026
11-16-2026
Dividend Yield
★ 197.24%
N/A
EPS Growth
N/A
★ 2.78
EPS
★ N/A
N/A
Revenue
N/A
★ $33,587,000.00
Revenue This Year
$127.02
$14.93
Revenue Next Year
$36.19
$18.26
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 19.74
52 Week Low
$0.09
$0.58
52 Week High
$0.83
$4.94

Technical Indicators

Market Signals
Indicator
GNS
RPID
Relative Strength Index (RSI) 90.23 44.20
Support Level $0.36 $0.58
Resistance Level N/A $0.79
Average True Range (ATR) 0.03 0.05
MACD 0.02 0.02
Stochastic Oscillator 59.66 74.26

Price Performance

Historical Comparison
GNS
RPID

About GNS Genius Group Limited

Genius Group Ltd is an Edtech and education company that provides entrepreneur education system business development tools and management consultancy services to entrepreneurs and entrepreneur resorts. Its revenue is derived from five reportable segments: Central, Academy, School, Resorts, and Discontinued operations. Geographically, it operates in Europe/Middle East/Africa, Asia/Pacific, and North America/South America.

About RPID Rapid Micro Biosystems Inc.

Rapid Micro Biosystems Inc is a life sciences technology company. Its technology uses a sensitive camera and the natural autofluorescence of living cells to identify and quantify microbial growth faster and more accurately than the traditional method, which relies on the human eye. The company develops, manufactures, markets, and sells Growth Direct systems (Systems), proprietary consumables, laboratory information management system (LIMS) connection, and other software and services to address rapid microbial analysis used for quality control in the manufacture of pharmaceuticals, medical devices, and personal care products. Geographically, it generates maximum revenue from the United States, and the rest from Switzerland, Germany, Japan, and all other countries.

Share on Social Networks: